T
Thomas F. Lüscher
Researcher at University of Zurich
Publications - 1613
Citations - 88517
Thomas F. Lüscher is an academic researcher from University of Zurich. The author has contributed to research in topics: Endothelium & Myocardial infarction. The author has an hindex of 134, co-authored 1560 publications receiving 79034 citations. Previous affiliations of Thomas F. Lüscher include University of Texas Southwestern Medical Center & Durham University.
Papers
More filters
Journal ArticleDOI
Twenty-Four-Hour Secretory Pattern of Cortisol in the Bull: Evidence of Episodic Secretion and Circadian Rhythm
TL;DR: Results from this study indicate that there is a temporal correlation between the rhythm of cortisol secretion and the light-dark cycle in the bovine species.
Journal ArticleDOI
Angiotensin-Converting Enzyme Inhibition Improves Vascular Function in Rheumatoid Arthritis
Andreas J. Flammer,Isabella Sudano,Frank Hermann,Adrian Forster,Michel Neidhart,Peter Künzler,Frank Enseleit,Daniel Périat,Matthias Hermann,Juerg Nussberger,Thomas F. Lüscher,Roberto Corti,Georg Noll,Frank Ruschitzka +13 more
TL;DR: Findings suggest that angiotensin-converting enzyme inhibition with 10 mg/d ramipril for 8 weeks on top of current antiinflammatory treatment markedly improved endothelial function in patients with rheumatoid arthritis.
Journal ArticleDOI
Global position paper on cardiovascular regenerative medicine.
Francisco Fernández-Avilés,Ricardo Sanz-Ruiz,Andreu M. Climent,Lina Badimon,Lina Badimon,Roberto Bolli,Dominique Charron,Valentin Fuster,Valentin Fuster,Stefan Janssens,Jens Kastrup,Hyo-Soo Kim,Thomas F. Lüscher,Martin John Francis,Philippe Menasché,Robert D. Simari,Gregg W. Stone,Andre Terzic,Andre Terzic,James T. Willerson,Joseph C. Wu,C. Wu Joseph,Kathleen M. Broughton,Darcy L. DiFede,Stefanie Dimmeler,Rosalinda Madonna,Marc S. Penn,Mark A. Sussman,Joost P.G. Sluijter,Joost P.G. Sluijter,Kai C. Woller,Wayne Balkan,Steven A. J. Chamuleau,María Eugenia Fernández-Santos,Georg Goliasch,Georg Goliasch,Mariann Gyöngyösi,Mariann Gyöngyösi,Joshua M. Hare,Bryon A. Tompkins,Johannes Winkler,Antoni Bayes-Genis,Antoni Bayes-Genis,Timothy D. Henry,Doris A. Taylor,Amir Lerman,Beatriz Pelacho,Felipe Prosper,Emerson C. Perin,Giulio Pompilio,Bernard Gersh,Jozef Bartunek,Eric Duckers,Péter Ferdinandy,Péter Ferdinandy,Douglas W. Losordo,Pedro L. Čanchez,Warren Sherman,Wojtek Wojakowski,Andreas M. Zeiher,Jerome Roncalli,Anthony Mathur,Filippo Crea,Domenico D'Amario,Thomas J. Povsic,Jay H. Traverse,Seppo Ylä-Herttuala +66 more
TL;DR: The aim of this work is to contribute towards the humanizing of science and the promotion of knowledge and understanding of language and culture through research and education.
Journal ArticleDOI
Celecoxib Decreases Endothelial Tissue Factor Expression Through Inhibition of c-Jun Terminal NH2 Kinase Phosphorylation
Jan Steffel,Matthias Hermann,Helen Greutert,Thomas F. Lüscher,Frank Ruschitzka,Felix C. Tanner +5 more
TL;DR: Data indicate a distinct heterogeneity within this class of drugs, which may be clinically relevant, especially for patients with atherosclerotic vascular diseases.
Journal ArticleDOI
Rationale and design of Ferinject® Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR‐HF) study: a randomized, placebo‐controlled study of intravenous iron supplementation in patients with and without anaemia
Stefan D. Anker,Josep Comin Colet,Gerasimos Filippatos,Ronnie Willenheimer,Kenneth Dickstein,Kenneth Dickstein,Helmut Drexler,Thomas F. Lüscher,Claudio Mori,Barbara von Eisenhart Rothe,Stuart J. Pocock,Philip A. Poole-Wilson,Piotr Ponikowski +12 more
TL;DR: FAIR‐HF (Clinical Trials.gov NCT00520780) was designed to determine the effect of i.v. iron repletion therapy using ferric carboxymaltose on self‐reported patient global assessment (PGA) and New York Heart Association (NYHA) in patients with CHF and ID.